Zimmer Biomet HoldingsXSWX:ZBH +0.68%69 FCF Yield % is 7.60 as of Jun. 27, 2026, which is 42% above its 10-year median of 5.37. GuruFocus rates XSWX:ZBH with a GF Score™ of 69/100 and a GF Value™ of CHF100.92 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Zimmer Biomet Holdings ranks better than 90.99% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Zimmer Biomet Holdings's FCF Yield % or its related term are showing as below:
XSWX:ZBH'
s FCF Yield % Range Over the Past 10 Years
Min: 2.49 Med: 5.37 Max: 8.49
Current: 7.6
During the past 13 years, the highest FCF Yield % of Zimmer Biomet Holdings was 8.49%. The lowest was 2.49%. And the median was 5.37%.
XSWX:ZBH's FCF Yield % is ranked better than 90.99% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.38
vs XSWX:ZBH: 7.60
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Zimmer Biomet Holdings FCF Yield % Related Terms
Zimmer Biomet Holdings FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:ZBH vs PEN, GMED, STE: FCF Yield % Comparison
For the Medical Devices subindustry, Zimmer Biomet Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zimmer Biomet Holdings FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zimmer Biomet Holdings (XSWX:ZBH) has a FCF Yield % of 7.60 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Zimmer Biomet Holdings and its competitors. This is 42% above median its historical median of 5.37. Over the past decade, Zimmer Biomet Holdings' FCF Yield % has ranged from 2.49 to 8.49. According to the industry distribution chart, Zimmer Biomet Holdings ranks #77 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 9%.
Is Zimmer Biomet Holdings' FCF Yield % too high?
Zimmer Biomet Holdings' current FCF Yield % of 7.60 is 42% above median its 10-year median of 5.37. Over the past 10 years, this metric has ranged from a low of 2.49 to a high of 8.49. Based on the distribution chart, Zimmer Biomet Holdings ranks #77 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Zimmer Biomet Holdings has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' FCF Yield % compare to PEN and GMED?
According to the Medical Devices & Instruments industry distribution chart, Zimmer Biomet Holdings ranks #77 out of 855 companies for FCF Yield %. This places Zimmer Biomet Holdings in the top 9% of its industry — outperforming the majority of peers. Historically, Zimmer Biomet Holdings' own FCF Yield % has ranged from 2.49 to 8.49 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current FCF Yield % is 7.60, which is 42% above median its own 10-year median of 5.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zimmer Biomet Holdings (XSWX:ZBH) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF100.92, compared to a current price of CHF74.50 — trading 26.2% below its estimated fair value. The current FCF Yield % is 7.60, which is 42% above median its 10-year median of 5.37. Zimmer Biomet Holdings' overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current FCF Yield % is 7.60 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?
Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued.
The current stock price of CHF74.50 is trading 26.2% below its estimated GF Value™ of CHF100.92.
GuruFocus considers Zimmer Biomet Holdings to be Modestly Undervalued.
Key valuation signals for XSWX:ZBH:
FCF Yield %: 7.60 (42% above median its 10-year median of 5.37)
GF Value™: CHF100.92 vs. price of CHF74.50 (26.2% below fair value)
No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
69GF Score
Get the complete analysis for XSWX:ZBH
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ZBH has been successfully added to your 
